top of page

Title: Stocks firm on Europe's last full trading day

Writer's picture: analysiswatchanalysiswatch

Dec 30, 2021 05:00AM ET


By: AnalysisWatch


European stocks edged higher on Thursday on hopes that no new coronavirus-related restrictions would be needed in the New Year, although a rise in COVID-19 cases due to the Omicron variant held back gains.


The pan-European STOXX 600 rose 0.2% after falling 0.1% on Wednesday, led by the technology sector and defensive stocks including healthcare and real estate.


Spain's IBEX index was unchanged after consumer prices rose 6.7% nationwide in December from a year earlier, the fastest annual rise in inflation since 1989.


The index underperformed its regional peers in 2021, gaining only 7%, while the STOXX 600 rose 22%.


Meanwhile, France's CAC 40 outperformed the benchmark's gains in 2021 as hopes for an economic recovery boosted luxury stocks, even as the outlook for Asian demand remains bleak going into the New Year.


The blue-chip index is up 29% in 2021 and is heading for its best year in more than two decades, outperforming even the S&P 500's 27% rise.


Global COVID Reuters data showed on Wednesday that 19 infections hit a record high in the past seven days as countries try to balance omicron restrictions while keeping economies open.


British Prime Minister Boris Johnson said earlier this week that he would not introduce any new pandemic-related restrictions this year, while a curfew for mainland France was ruled out.


Researchers said on Thursday that a booster dose of Johnson & Johnson's COVID-19 vaccine was 84% effective in preventing hospitalizations among South African health workers infected by the Omicron spread.



0 views0 comments

Comments


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page